ERGO (Entia Biosciences) FCF Yield %: 0.00 (As of Jul. 01, 2026)


What is Entia Biosciences FCF Yield %?

Entia Biosciences ERGO FCF Yield % is 0.00 as of Jul. 01, 2026.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Entia Biosciences's Trailing 12-Month Free Cash Flow is $-0.72 Mil, and Market Cap is $0.01 Mil. Therefore, Entia Biosciences's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Entia Biosciences's FCF Yield % or its related term are showing as below:


ERGO's FCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -9.46
* Ranked among companies with meaningful FCF Yield % only.

Entia Biosciences's FCF Margin % for the quarter that ended in Dec. 2016 was -956.52%.

Entia Biosciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Entia Biosciences FCF Yield % Related Terms

Entia Biosciences FCF Yield % Historical Data

* Premium members only.

The historical data trend for Entia Biosciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entia Biosciences FCF Yield % Chart

Entia Biosciences Annual Data
Trend Jul07 Jul08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.15 -16.71 -22.80 -22.06 -45.80

Entia Biosciences Quarterly Data
Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.49 -18.48 -29.85 -23.37 -111.65

ERGO vs OBMP, NSPX, ATRX: FCF Yield % Comparison

For the Biotechnology subindustry, Entia Biosciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entia Biosciences FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entia Biosciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Entia Biosciences's FCF Yield % falls into.


Entia Biosciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Entia Biosciences's FCF Yield % for the fiscal year that ended in Dec. 2016 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.722 / 1.5764
=-45.80%

Entia Biosciences's annualized FCF Yield % for the quarter that ended in Dec. 2016 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.44 * 4 / 1.5764
=-111.65%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 0.00 mean?
Entia Biosciences (ERGO) has a FCF Yield % of 0.00 as of Jul. 01, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Entia Biosciences and its competitors.
Is Entia Biosciences' FCF Yield % too high?
Entia Biosciences' current FCF Yield % is 0.00.
How does Entia Biosciences' FCF Yield % compare to OBMP and NSPX?
Entia Biosciences' FCF Yield % of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Entia Biosciences and its competitors. Entia Biosciences's current FCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entia Biosciences stock overvalued right now?
Entia Biosciences (ERGO) has a current FCF Yield % of 0.00. The current FCF Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Entia Biosciences (ERGO), the current FCF Yield % is 0.00 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entia Biosciences Business Description

Address 13565 South West Tualatin-Sherwood Road, Suite 800, Sherwood, OR, USA, 97140
Entia Biosciences Inc operates as a biotechnology company, is engaged in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products, principally in the United States of America. It market nutraceutical products under the name GROH and SANO directly to the consumers online. It currently offers natural organic nutraceutical mushroom dietary supplement products, ImmuSANO, GlucoSANO, and GROH, which has been designed to nutritionally support hair follicles and nail beds. It derives its revenue from the sale of its GROH line and mushroom-based nutraceutical dietary supplement products and functional ingredients.